A detailed history of Dorsey & Whitney Trust CO LLC transactions in Nevro Corp stock. As of the latest transaction made, Dorsey & Whitney Trust CO LLC holds 11,553 shares of NVRO stock, worth $59,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,553
Previous 11,553 -0.0%
Holding current value
$59,613
Previous $97,000 34.02%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$7.96 - $13.59 $318 - $543
-40 Reduced 0.35%
11,553 $97,000
Q1 2024

May 09, 2024

BUY
$13.56 - $20.78 $135 - $207
10 Added 0.09%
11,593 $167,000
Q4 2023

Feb 12, 2024

SELL
$14.18 - $22.31 $125,932 - $198,135
-8,881 Reduced 43.4%
11,583 $249,000
Q3 2023

Nov 08, 2023

BUY
$18.22 - $25.85 $74,519 - $105,726
4,090 Added 24.98%
20,464 $393,000
Q1 2022

May 11, 2022

BUY
$59.95 - $92.06 $981,621 - $1.51 Million
16,374 New
16,374 $1.18 Million
Q4 2021

Feb 08, 2022

SELL
$81.07 - $121.29 $1.33 Million - $1.99 Million
-16,374 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$132.81 - $182.18 $5,046 - $6,922
-38 Reduced 0.23%
16,374 $2.28 Million
Q3 2020

Nov 12, 2020

SELL
$114.09 - $145.51 $399,315 - $509,284
-3,500 Reduced 17.58%
16,412 $2.29 Million
Q1 2020

May 12, 2020

BUY
$70.23 - $144.31 $2,668 - $5,483
38 Added 0.19%
19,912 $1.99 Million
Q4 2019

Feb 06, 2020

SELL
$76.41 - $117.54 $5,577 - $8,580
-73 Reduced 0.37%
19,874 $2.34 Million
Q1 2018

May 08, 2018

SELL
$69.46 - $88.57 $500,945 - $638,766
-7,212 Reduced 26.55%
19,947 $1.73 Million
Q4 2017

Feb 13, 2018

SELL
$65.94 - $93.31 $46,949 - $66,436
-712 Reduced 2.55%
27,159 $1.88 Million
Q3 2017

Nov 13, 2017

BUY
$80.87 - $91.08 $2.25 Million - $2.54 Million
27,871
27,871 $2.53 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $183M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Dorsey & Whitney Trust CO LLC Portfolio

Follow Dorsey & Whitney Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey & Whitney Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey & Whitney Trust CO LLC with notifications on news.